Breaking News Instant updates and real-time market news.

GE

General Electric

$6.77

-0.15 (-2.17%)

, F

Ford

$8.54

0.015 (0.18%)

07:30
12/12/18
12/12
07:30
12/12/18
07:30

Unusual put flow in option market yesterday

Notable put activity was cited Tuesday in General Electric (GE), Ford (F), Schlumberger (SLB), Coca Cola (KO), Aurora Cannabis (ACB), First Solar (FSLR), Under Armour (UA), Restaurant Brands (QSR), and Garmin (GRMN).

GE

General Electric

$6.77

-0.15 (-2.17%)

F

Ford

$8.54

0.015 (0.18%)

SLB

Schlumberger

$41.24

-0.72 (-1.72%)

KO

Coca-Cola

$49.54

0.29 (0.59%)

ACB

Aurora Cannabis

$5.93

0.22 (3.85%)

FSLR

First Solar

$42.43

-0.79 (-1.83%)

UA

Under Armour

$20.87

-0.15 (-0.71%)

QSR

Restaurant Brands

$52.98

-0.81 (-1.51%)

GRMN

Garmin

$65.37

0.41 (0.63%)

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

  • 18

    Dec

  • 18

    Dec

  • 18

    Dec

  • 18

    Jan

  • 23

    Jan

  • 03

    Mar

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

GE General Electric
$6.77

-0.15 (-2.17%)

12/10/18
SUSQ
12/10/18
NO CHANGE
Target $24
SUSQ
Neutral
GE stake in Baker Hughes remains an overhang, says Susquehanna
Susquehanna analyst Charles Minervino said Baker Hughes (BHGE) management expressed optimism about its end market diversification, global oilfield footprint and robust backlog in recent meetings and noted the company has not made any changes to its outlook assumptions disclosed on the Q3 call. While he thinks Baker Hughes has done "a very admirable job" of managing the new organization since the GE (GE) merger, Minervino keeps a Neutral rating on the stock given the lingering GE 50.4% ownership overhang. After lowering his 2019 EPS estimate to $1.29 from $1.39 to account for model changes and the recent move in crude prices, Minervino lowered his price target on Baker Hughes shares to $24 from $31.
11/20/18
GDHS
11/20/18
NO CHANGE
Target $10
GDHS
Underperform
GE 'fire sale' of Baker Hughes stake a 'net negative,' says Gordon Haskett
Gordon Haskett analyst John Inch, who maintains an Underperform rating and $10 price target on General Electric (GE) shares, said the sale of Baker Hughes (BHGE) shares generates cash and in theory should be a credit "positive", but given that the sale is being done so far below book value leads him to conclude it is instead a net "negative." Even though GE should realize about $3.8B in proceeds from the sale, Inch believes the company's balance sheet could come under further stress given likely additional write-downs associated with the "fire sale" of Baker Hughes sales, he tells investors.
11/30/18
DBAB
11/30/18
NO CHANGE
Target $7
DBAB
Hold
Deutsche, laying out 'realistic bear case,' cuts GE target to $7 from $11
Deutsche Bank analyst Nicole DeBlase thinks the key debates over General Electric can be boiled down to the trajectory of GE Industrial free cash flow and whether the company is headed for a liquidity crisis. In a new research report titled "Laying Out a Realistic Bear Case," the analyst walks through a new base and bear case free cash flow analyses. The bad news is that in the bear case, GE Industrial free cash flow remains in negative territory through 2021, DeBlase writes. The analyst built up a segment-by-segment bear case earnings model, which assumes continued declines at Power and modest downturns in Renewables, Aviation and O&G. The "good news," however, is that even in this "drastic scenario," the analyst does not foresee a liquidity crisis. Nevertheless, the analyst cut her price target for General Electric shares to $7 from $11 and keeps a Hold rating on the name. The stock closed yesterday up 20c to $7.94. DeBlase's price target relies on her base case, not her bear case. Her base case "embodies a more likely scenario," whereby an economic downturn does not happen through 2021.
11/30/18
DBAB
11/30/18
NO CHANGE
Target $7
DBAB
Hold
General Electric price target lowered to $7 from $11 at Deutsche Bank
Deutsche Bank analyst Nicole DeBlase lowered his price target for General Electric to $7 from $11 and keeps a Hold rating on the shares after laying out what she believes to be a "realistic bear case."
F Ford
$8.54

0.015 (0.18%)

11/27/18
MSCO
11/27/18
NO CHANGE
MSCO
Equal Weight
Ford's biggest challenges must be confronted alone, says Morgan Stanley
Morgan Stanley analyst Adam Jonas said Ford (F) shares have been moving on hopes of significant cooperation with Volkswagen (VLKAY) following the signing of an MOU between the two automakers last June. While he believes VW and Ford have some "extremely complementary areas of weakness and strength" and he sees scope for a VW collaboration to save Ford $2B-$4B annually or more, Jonas also contends that Ford's "biggest challenges must be confronted alone." He added that a full merger or "grand alliance" is a long shot and Jonas does not expect a significant flow of capital from Ford to VW or vice versa at this stage. He maintains an Equal Weight rating on Ford shares, stating that General Motors' (GM) restructuring announcement will focus investor attention on Ford's next steps.
12/10/18
GSCO
12/10/18
DOWNGRADE
Target $63
GSCO
Sell
Goldman downgrades Visteon to Sell with 2019 'likely another down year'
Goldman Sachs analyst David Tamberrino downgraded Visteon (VC) to Sell from Neutral and lowered his price target for the shares to $63 from $83. The analyst sees risk to the company's 2021 targets with 2019 "likely another down year." He believes Visteon will continue to underperform peers in an "already difficult" environment for Autos. Visteon's upcoming business update will likely to be a negative catalyst due to "soft" 2019 guidance, lowered 2021 targets, and backlog revisions, Tamberrino tells investors in a research note. Further, the analyst sees potential for additional volume and pricing pressure given Visteon's (F) high Ford exposure as well as a lower likelihood of a takeout.
11/27/18
MSCO
11/27/18
NO CHANGE
MSCO
Equal Weight
Morgan Stanley sees Ford announcing similar steps to GM 'relatively soon'
After General Motors (GM) announced plans to close or not to allocate product to 7 plants globally and cut 15% of its global salaried work force, Morgan Stanley analyst Adam Jonas said the news was a surprise and that the timing is "unusually proactive by auto company standards," though he sees the steps as necessary to ensuring GM's long-term sustainability and independence. He also said there is a reason you don't typically see "thriving" auto companies cut thousands of jobs at high points in the cycle, as Jonas expects the labor and political response as "likely to be severe." Jonas added that he thinks GM's restructuring addresses a range of issues facing all automakers and he is prepared for Ford (F) to announce a series of actions similar to what GM has announced "relatively soon." Jonas has an Overweight rating on GM shares and an Equal Weight rating on Ford.
12/03/18
MSCO
12/03/18
NO CHANGE
Target $10
MSCO
Equal Weight
Ford restructuring could involve more job cuts than GM, says Morgan Stanley
Morgan Stanley analyst Adam Jonas noted that General Motors' (GM) headcount cuts have "attracted political attention at the highest level," but he thinks Ford (F) could announce potentially even larger cuts, estimating that the automaker's restructuring plan involves as many as 25,000 job reductions globally. Jonas estimates a large portion of Ford's restructuring actions will be focused on Ford Europe, but he also expects a significant restructuring effort in North America involving employees of both the UAW and CAW unions. The analyst contends this "is not just a GM or a Ford thing" and believes "existential business model risk" will be prioritized over near-term profits and cash return. Jonas has an Equal Weight rating and $10 price target on Ford shares.
SLB Schlumberger
$41.24

-0.72 (-1.72%)

11/26/18
HSBC
11/26/18
UPGRADE
HSBC
Buy
Schlumberger upgraded to Buy from Hold at HSBC
12/06/18
JEFF
12/06/18
NO CHANGE
Target $54
JEFF
Buy
Schlumberger price target lowered to $54 from $75 at Jefferies
Jefferies analyst Brad Handler lowered his price target for Schlumberger to $54 saying the company's Q4 comments "surprised with the relative severity of the pumping drop and raise concerns about non-NAM revenue growth in 2019." The analyst believes concerns about pumping competitiveness and global oil-skittishness" weighing on upstream spending will challenge what earnings multiples are warranted. The analyst, however, keeps a Buy rating on Schlumberger.
12/11/18
JPMS
12/11/18
DOWNGRADE
Target $48
JPMS
Neutral
Schlumberger downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Sean Meakim downgraded Schlumberger to Neutral and lowered his price target for the shares to $48 from $73. The analyst moderated the pace of U.S. activity in his earnings models for 2019. He believes it will be difficult to envision a reversal in shares of Schlumberger without a material change in offshore fundamentals.
10/22/18
FBCO
10/22/18
NO CHANGE
Target $71
FBCO
Outperform
Schlumberger price target lowered to $71 from $82 at Credit Suisse
Credit Suisse analyst Jim Wicklund lowered his price target for Schlumberger to $71 from $82 following quarterly results. The analyst reiterates an Outperform rating on the shares.
KO Coca-Cola
$49.54

0.29 (0.59%)

11/09/18
GSCO
11/09/18
UPGRADE
Target $66
GSCO
Conviction Buy
Monster Beverage upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman analyst Judy Hong added Monster Beverage to the Conviction Buy List saying concerns over the dispute Coca-Cola (KO) are overdone and recommends buying shares on weakness. Hong believes Monster's shares downside is limited from a Coca-Cola Energy launch and does not believe the partnership is in jeopardy. The analyst sees upside to consensus 2019/20 estimates and a path to her $66 price target based on mid-teens plus earnings growth.
11/09/18
BMOC
11/09/18
NO CHANGE
Target $60
BMOC
Outperform
Monster Beverage price target lowered to $60 from $70 at BMO Capital
BMO Capital analyst Amit Sharma lowered his price target on Monster Beverage (MNST) to $60 to reflect its selloff yesterday on reported possibility of Coca-Cola (KO) entering the energy drink category. The analyst notes however that while the threat may pose a near-term overhang on the stock, the impact on its growth and valuation is likely overblown. Sharma cites the "deep economic alignment" between the two companies and their bottlers, along with the company's willingness to find an acceptable resolution. The analyst also keeps his Outperform rating on Monster Beverage.
11/09/18
SBSH
11/09/18
NO CHANGE
Target $56
SBSH
Buy
Coca-Cola should trade at a 50% premium to market, says Citi
After spending time in Europe with CEO James Quincey, Citi analyst Wendy Nicholson says her confidence in Coca-Cola "continues to go up." Given her confidence in the company's ability to deliver on its growth targets, she continues to believe the stock should trade at a 50% premium to the market. The analyst raised her price target for Coca-Cola shares to $56 from $54 and keeps a Buy rating on the name.
11/08/18
SUSQ
11/08/18
NO CHANGE
Target $46
SUSQ
Negative
Monster Beverage results solid, but Coke conflict an overhang, says Susquehanna
Susquehanna analyst Pablo Zuanic said Monster Beverage (MNST) reported solid Q3 earnings, though gross margins missed again. However, he thinks a price hike effective on November 1 should mitigate the gross margin pressure. He believes a budding conflict with Coca-Cola (KO) could call into question the company's ability to grow and will be an overhang on the stock. Zuanic reiterated his Negative rating, though he raised his price target to $46 from $44 on Monster Beverage shares.
ACB Aurora Cannabis
$5.93

0.22 (3.85%)

11/07/18
ADAM
11/07/18
NO CHANGE
ADAM
Midterms broadly positive for U.S. cannabis industry, says Canaccord
Canaccord analyst Bobby Burleson says that as expected, yesterday's midterms delivered several wins for the U.S. cannabis industry, including the passage of three state ballot measures on legalization, key gubernatorial victories by pro-cannabis candidates, and the retaking of the House by Democrats. The analyst views these results as broadly positive for the U.S. cannabis industry. Publicly traded companies in the space include Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC) and Tilray (TLRY).
FSLR First Solar
$42.43

-0.79 (-1.83%)

12/12/18
UBSW
12/12/18
NO CHANGE
Target $73
UBSW
Buy
First Solar price target lowered to $73 from $85 at UBS
UBS analyst Jon Windham lowered his price target for First Solar to $73 but keeps a Buy rating on the name following last night's 2019 guidance. The good news is that the underlying profitability for Series 6 appears to be materializing, Windham tells investors in a research note. The bad news, however, is that start-up expenses are likely to weigh on 2019 overall operating margins, adds the analyst. While Windham says it is not a great idea to play a "waiting game" with solar stocks, he views First Solar's valuation as "relatively depressed" at current share levels.
12/07/18
ROTH
12/07/18
NO CHANGE
Target $65
ROTH
Buy
First Solar has 'clear path' to attractive cost structure, says Roth Capital
Roth Capital analyst Philip Shen maintained a Buy rating and $65 price target on First Solar ahead of its 2019 guidance call next week. In a research note to investors, Shen says checks suggest the company may be one quarter late in fully ramping up its first S6 facilities in Ohio and Malaysia, but key hurdles have been overcome and management has a "clear path" to reaching an attractive cost structure.
12/04/18
12/04/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Waste Management (WM) double upgraded to Buy from Sell at Goldman Sachs with analyst Brian Maguire saying given the age of the current business cycle and expectations for slowing economic growth, now is the right time to own Waste stocks. 2. RMR Group (RMR) upgraded to Buy from Neutral at B. Riley FBR with analyst Bryan Maher citing valuation. 3. Keurig Dr Pepper (KDP) upgraded to Outperform from Neutral at Macquarie. 4. First Solar (FSLR) upgraded to Buy from Hold at Argus with analyst David Coleman citing the company's position in the solar industry with "positive cash flow, solid balance sheet, and focus on cadmium telluride technology, which should provide a cost advantage relative to more commoditized technologies." 5. Sherwin-Williams (SHW) upgraded to Buy from Hold at Deutsche Bank with analyst Nishu Sood saying he believes the paths for housing construction and remodeling "could diverge," which leaves him preferring remodeling focused names versus new construction exposed names. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/04/18
ARGS
12/04/18
UPGRADE
Target $60
ARGS
Buy
First Solar upgraded to Buy from Hold at Argus
As reported earlier, Argus analyst David Coleman upgraded First Solar to Buy from Hold with a price target of $60. The analyst cites the company's position in the solar industry with "positive cash flow, solid balance sheet, and focus on cadmium telluride technology, which should provide a cost advantage relative to more commoditized technologies." Coleman adds that First Solar shares have underperformed over the past 3 months with a 13% decline but believes that the stock is "attractively valued" at 15.5-times his expected forward earnings, which is in the lower half of its 4.5- to 37.7-times historical range.
UA Under Armour
$20.87

-0.15 (-0.71%)

12/03/18
JEFF
12/03/18
NO CHANGE
JEFF
Under Armour discounts down for eighth straight month, says Jefferies
Jefferies analyst Randal Konik says his firm's November webscrapes illustrate that Under Armour's (UAA) percentage of product on discount is down for the eighth month in a row, while Adidas's (ADDYY) is up nine months in a row. Visits to Finish Line (FINL), Foot Locker (FL), and Under Armour websites reveal the HOVR, Project Rock, and Curry 5 are sold out in several sizes/colors, indicating growing brand momentum, Konik tells investors in a research note titled "SNEAKER WARS: Santa's Sleigh Won't Fly This Holiday, It Will HOVR." Further, Nike (NKE) continues its dominance over Adidas in running in the U.S., with strength in Air VaporMax and Air Max 270, says the analyst.
11/30/18
11/30/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. UDR, Inc. (UDR) upgraded to Buy from Hold at Jefferies with analyst Omotayo Okusanya saying the company's above average net operating income growth and development pipeline position it to be one of the best funds from operations growth stories in 2019. 2. Under Armour (UAA) upgraded to Market Perform from Underperform at Wells Fargo with analyst Tom Nikic saying after two-plus years of "choppy operating performance," the worst is now over for Under Armour. 3. WWE (WWE) upgraded to Overweight from Neutral at JPMorgan with analyst David Karnovsky saying shares are off 26% from peak levels reached at the end of September and now trade at 14.5 times estimated 2020 adjusted OIBDA. 4. Volaris (VLRS) upgraded to Hold from Reduce at HSBC. 5. Sony (SNE) upgraded to Buy from Neutral at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/06/18
PIPR
12/06/18
NO CHANGE
Target $32
PIPR
Overweight
Piper sees Under Armour shares 'working' after Dec. 12 analyst day
Piper Jaffray analyst Erinn Murphy remains positive on Under Armour (UAA) and sees the shares "working" following the company's analyst day on December 12. She expects management to detail a five-year plan with an improved operational/return on investment focus in addition to 2019 guidance. Murphy continues to see "significant" margin expansion in the coming years for Under Armour and keeps an Overweight rating on the shares with a $32 price target. Further, the analyst believes the company's promotional stance has been "well controlled" in Q4.
12/10/18
JEFF
12/10/18
NO CHANGE
Target $30
JEFF
Buy
Jefferies believes Under Armour 'will deliver' at this week's analyst day
Jefferies analyst Randal Konik believes Under Armour management "will deliver" at the company's analyst day on December 12. With a positive secular backdrop in wellness, limited competition and a "strong brand with global awareness yet still in the early innings of growth," Under Armour has an opportunity to show it's becoming a better run company for the long-term at its first analyst day in three years, Konik tells investors in a research note. He recommends buying the shares and keeps a Buy rating on the name with a $30 price target.
QSR Restaurant Brands
$52.98

-0.81 (-1.51%)

12/06/18
COWN
12/06/18
NO CHANGE
Target $71
COWN
Outperform
Restaurant Brands named a Best Idea for 2019 at Cowen
Cowen analyst Andrew Charles called Restaurant Brands a Best Idea for 2019. He noted the shares bottomed at a 3.5% yield three times during 2018. With an expected dividend increase of 10%, he calculates a floor in at $57 a share. He also said if a recovery at Tim Hortons fails to materialize, the break up value of the company implies a $69 per share value. Charles reiterated his Outperform rating and lowered his price target to $71 from $74 on Restaurant Brands shares.
10/19/18
OPCO
10/19/18
NO CHANGE
Target $75
OPCO
Outperform
Restaurant Brands' risk/reward attractive ahead of Q3 results, says Oppenheimer
Oppenheimer analyst Brian Bittner reiterated an Outperform rating and $75 price target on Restaurant Brands ahead of its quarterly results. In a research note to investors, Bittner says he remains attracted to the company's risk/reward and believes stock has already priced in sluggish Tim Horton's/Burger King SSS in 3Q.
12/03/18
WEDB
12/03/18
NO CHANGE
WEDB
Del Taco, ObsEva added to Best Ideas List at Wedbush
Wedbush expects visibility in 2019 into Del Taco's (TACO) long-term MSD-HSD EBITDA growth algorithm to result in valuation expansion toward its regional Restaurant Brands (QSR) peers, and is adding the stock to its Best Ideas List. Reiterating an Overweight rating on the shares and also adding it to its Best Ideas List, Wedbush says ObsEva (OBSV) continues to deliver stellar clinical results from its drug candidate pipeline. The firm anticipates Linzagolix to be the third entrant in the oral gonadotropin releasing hormone receptor antagonist space, but its differentiated profile and dosing options are likely to be preferred by patients.
11/14/18
OPCO
11/14/18
NO CHANGE
Target $92
OPCO
Outperform
Jack in the Box price target lowered to $92 from $105 at Oppenheimer
Oppenheimer analyst Brian Bittner lowered his price target for Jack in the Box (JACK) to $92 form $105 as he expects a sales miss against sell-side's stale Q4 estimates, particularly after analyzing the slower recent trends across the Restaurant Brands (QSR) peers. The analyst notes that this appears reflected in buyside expectations given stock's underperformance since last print and a valuation that sits lowest in his coverage universe. He reiterates an Outperform rating on the shares.
GRMN Garmin
$65.37

0.41 (0.63%)

09/20/18
LBOW
09/20/18
NO CHANGE
Target $75
LBOW
Buy
Garmin wearables segment to top estimates in Q3, says Longbow
Longbow analyst Joe Wittine raised his Garmin price target to $75 from $72 and kept his Buy rating, saying his sell-through indicators suggest that the company's wearables sales will exceed consensus forecasts. The analyst is positive on Garmin's Fitness segment, raising his forecast based on the web search data in the quarter, and also sees the Outdoor segment results above the Street in spite of the channel fill timing related trim. Wittine believes that Garmin can deliver sales and earnings beats through 2019 thanks to "peak ADS-B installs, further expansion in advanced wearables, and some narrowing in Auto declines".
08/27/18
MSCO
08/27/18
INITIATION
Target $20
MSCO
Equal Weight
Sonos initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Katy Huberty started Sonos (SONO) with an Equal Weight rating and $20 price target, stating that she believes timely launches and consumer receptivity to new products will be the most important drivers of earnings growth. She thinks the multiple will contract similar to how Fitbit (FIT) and GoPro's (GPRO) did after their initial product missteps if Sonos' new products fail to meet expectations, but the stock could trade closer to companies such as Logitech (LOGI) and Garmin (GRMN) if new products outperform. Given this wide risk/reward, she would prefer to await evidence of Beam or other new products beating forecasts, Huberty tells investors in her initiation note.
07/19/18
LBOW
07/19/18
NO CHANGE
Target $72
LBOW
Buy
Longbow predicts Q2 updside, guidance raise coming from Garmin
Longbow analyst Joe Wittine said his survey of aftermarket aviation dealers and distributors points to a positive inflection in Q2, driven in large part by ADS-B activity, and he also notes that early "fenix 5 Plus" search data points look good. Given his checks in the aviation and outdoor markets, as well as still-improving indicators for fitness, Wittine expects Q2 sales and EPS upside from Garmin and predicts the company will raise its 2018 guidance. He increased his price target on Garmin shares to $72 from $70 and keeps a Buy rating on the stock.
12/15/17
TIGR
12/15/17
NO CHANGE
TIGR
Garmin growth accelerating despite decline in auto nav products, says Tigress
Tigress Financial analyst Ivan Feinseth reiterated a Buy rating on Garmin sahres, noting the company's business performance continues to accelerate "driven by the growth of aviation and advanced wearables offsetting declines in automotive personal navigation products." Feinseth was also positive on Garmin's "significant" cash and cash flow, which allow the company to fund new product development, pursue acquisitions, and return capital to shareholders.

TODAY'S FREE FLY STORIES

PTC

PTC

$84.73

-1.14 (-1.33%)

20:28
01/23/19
01/23
20:28
01/23/19
20:28
Recommendations
PTC analyst commentary  »

PTC price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

UNP

Union Pacific

$154.20

-0.8 (-0.52%)

, BMY

Bristol-Myers

$49.92

0.21 (0.42%)

20:25
01/23/19
01/23
20:25
01/23/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

UNP

Union Pacific

$154.20

-0.8 (-0.52%)

BMY

Bristol-Myers

$49.92

0.21 (0.42%)

LUV

Southwest

$50.97

0.425 (0.84%)

MKC

McCormick

$139.03

0.31 (0.22%)

FCX

Freeport McMoRan

$12.30

-0.08 (-0.65%)

GWW

Grainger

$297.12

-3.29 (-1.10%)

AAL

American Airlines

$31.57

-1.18 (-3.60%)

HBAN

Huntington Bancshares

$13.56

0.05 (0.37%)

TXT

Textron

$49.19

0.76 (1.57%)

JBLU

JetBlue

$17.23

-0.13 (-0.75%)

AEP

American Electric

$77.00

0.65 (0.85%)

TAL

TAL Education

$31.21

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 28

    Jan

  • 07

    Feb

  • 18

    Feb

  • 28

    Feb

  • 18

    May

  • 20

    May

ADTN

Adtran

$12.25

0.49 (4.17%)

20:14
01/23/19
01/23
20:14
01/23/19
20:14
Earnings
Adtran reports Q4 adjusted EPS (12c), consensus (3c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

MSFT

Microsoft

$106.77

0.91 (0.86%)

, GOOGL

Alphabet Class A

$1,085.27

6.59 (0.61%)

20:10
01/23/19
01/23
20:10
01/23/19
20:10
Periodicals
China blocks Microsoft's Bing search engine, FT reports »

China regulators have…

MSFT

Microsoft

$106.77

0.91 (0.86%)

GOOGL

Alphabet Class A

$1,085.27

6.59 (0.61%)

BIDU

Baidu

$163.22

2.81 (1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 30

    Jan

  • 04

    Feb

  • 25

    Feb

  • 03

    Mar

  • 04

    Mar

  • 06

    Mar

  • 07

    Mar

EBAY

eBay

$32.62

-0.3 (-0.91%)

20:03
01/23/19
01/23
20:03
01/23/19
20:03
Recommendations
eBay analyst commentary  »

eBay should consider…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

CLR

Continental Resources

$45.30

-0.27 (-0.59%)

20:00
01/23/19
01/23
20:00
01/23/19
20:00
Conference/Events
Continental Resources to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

APY

Apergy

$33.20

-0.35 (-1.04%)

19:55
01/23/19
01/23
19:55
01/23/19
19:55
Initiation
Apergy initiated  »

Apergy initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

  • 19

    Feb

AMZN

Amazon.com

$1,641.50

7.35 (0.45%)

19:15
01/23/19
01/23
19:15
01/23/19
19:15
Hot Stocks
AWS unveils Amazon WorkLink solution »

Amazon Web Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 28

    Jan

  • 31

    Jan

  • 04

    Feb

  • 20

    Feb

  • 03

    Mar

SMBK

SmartFinancial

$18.35

0.21 (1.16%)

19:08
01/23/19
01/23
19:08
01/23/19
19:08
Earnings
SmartFinancial reports Q4 operating EPS 43c, consensus 37c »

SmartFinancial Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

MLRYY

Mail.Ru Group

$0.00

(0.00%)

19:05
01/23/19
01/23
19:05
01/23/19
19:05
Downgrade
Mail.Ru Group rating change  »

Mail.Ru Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$152.03

-0.1 (-0.07%)

18:58
01/23/19
01/23
18:58
01/23/19
18:58
Periodicals
Zhongnan Group to buy Alibaba-backed EasyHome for CNY38B, Bloomberg says »

Alibaba owns a 15% stake…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 03

    Mar

  • 04

    Mar

JPM

JPMorgan

$102.72

-0.23 (-0.22%)

18:55
01/23/19
01/23
18:55
01/23/19
18:55
Periodicals
JPMorgan exec says private bank expands ops in Mexico, Reuters says »

JPMorgan's private…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

SLM

Sallie Mae

$9.49

0.1 (1.07%)

, XLNX

Xilinx

$89.55

-0.89 (-0.98%)

18:53
01/23/19
01/23
18:53
01/23/19
18:53
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: SLM…

SLM

Sallie Mae

$9.49

0.1 (1.07%)

XLNX

Xilinx

$89.55

-0.89 (-0.98%)

AZPN

Aspen Technology

$89.08

0.22 (0.25%)

LRCX

Lam Research

$139.24

-0.58 (-0.41%)

URI

United Rentals

$115.98

-2.21 (-1.87%)

TER

Teradyne

$31.93

0.13 (0.41%)

VAR

Varian Medical

$126.83

1.57 (1.25%)

CP

Canadian Pacific

$195.71

0.02 (0.01%)

TXN

Texas Instruments

$95.49

-1.05 (-1.09%)

F

Ford

$8.34

-0.17 (-2.00%)

BGG

Briggs & Stratton

$13.73

-0.46 (-3.24%)

PTC

PTC

$84.73

-1.14 (-1.33%)

CTXS

Citrix

$108.64

0.4 (0.37%)

LVS

Las Vegas Sands

$57.25

0.26 (0.46%)

FFIV

F5 Networks

$159.65

2.5 (1.59%)

CCI

Crown Castle

$110.28

1.13 (1.04%)

NCNA

NuCana

$14.37

-0.38 (-2.58%)

ADXS

Advaxis

$0.32

-0.0283 (-8.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 28

    Jan

  • 28

    Jan

  • 29

    Jan

  • 29

    Jan

  • 30

    Jan

  • 11

    Feb

  • 14

    Feb

  • 25

    Feb

  • 25

    Mar

  • 26

    Mar

  • 25

    Apr

  • 28

    May

  • 24

    Jul

  • 23

    Oct

  • 25

    Jan

FB

Facebook

$144.35

-3.45 (-2.33%)

18:41
01/23/19
01/23
18:41
01/23/19
18:41
Periodicals
Advocacy groups pushing FTC to force Facebook breakup, WSJ says »

Multiple advocacy groups…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 30

    Jan

  • 25

    Feb

  • 03

    Mar

GOOG

Alphabet

$1,076.04

5.32 (0.50%)

, GOOGL

Alphabet Class A

$1,085.27

6.59 (0.61%)

18:38
01/23/19
01/23
18:38
01/23/19
18:38
Periodicals
Devs say Google's Chrome proposal threatens ad blockers, Bloomberg says »

Developers are…

GOOG

Alphabet

$1,076.04

5.32 (0.50%)

GOOGL

Alphabet Class A

$1,085.27

6.59 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 04

    Feb

  • 04

    Feb

  • 25

    Feb

  • 03

    Mar

FCPT

Four Corners Property Trust

$26.58

-0.09 (-0.34%)

, BLMN

Bloomin' Brands

$19.15

0.08 (0.42%)

18:36
01/23/19
01/23
18:36
01/23/19
18:36
Recommendations
Four Corners Property Trust, Bloomin' Brands analyst commentary  »

Four Corners Property…

FCPT

Four Corners Property Trust

$26.58

-0.09 (-0.34%)

BLMN

Bloomin' Brands

$19.15

0.08 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

BAC

Bank of America

$28.91

-0.18 (-0.62%)

18:11
01/23/19
01/23
18:11
01/23/19
18:11
Periodicals
Bank of America appoints Mike Joo as investment operating chief, Reuters says »

Head of global rates and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

  • 03

    Mar

F

Ford

$8.34

-0.17 (-2.00%)

18:08
01/23/19
01/23
18:08
01/23/19
18:08
Hot Stocks
Ford says Russian alliance 'under review' »

Says won't have to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

F

Ford

$8.34

-0.17 (-2.00%)

18:04
01/23/19
01/23
18:04
01/23/19
18:04
Hot Stocks
Breaking Hot Stocks news story on Ford »

Ford says 'not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

CHMG

Chemung Financial

$41.99

-0.11 (-0.26%)

18:04
01/23/19
01/23
18:04
01/23/19
18:04
Earnings
Chemung Financial reports Q4 EPS $1.18, consensus $1.04 »

Reports Q4 loan loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$8.34

-0.17 (-2.00%)

18:03
01/23/19
01/23
18:03
01/23/19
18:03
Hot Stocks
Breaking Hot Stocks news story on Ford »

Ford says 2019 will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

F

Ford

$8.34

-0.17 (-2.00%)

18:01
01/23/19
01/23
18:01
01/23/19
18:01
Hot Stocks
Ford says 2018 auto EBIT benefited from improvement of market factors »

Says auto EBIT in 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

HSIC

Henry Schein

$76.92

-0.45 (-0.58%)

17:56
01/23/19
01/23
17:56
01/23/19
17:56
Hot Stocks
Henry Schein falls after saying it will not be key supplier to VCA,Pet Partners »

Shares of Henry Schein…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSIC

Henry Schein

$76.92

-0.45 (-0.58%)

17:51
01/23/19
01/23
17:51
01/23/19
17:51
Hot Stocks
Henry Schein will no longer be key supplier to VCA and Pet Partners »

Mars, Incorporated has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOLX

Hologic

$44.40

0.22 (0.50%)

17:50
01/23/19
01/23
17:50
01/23/19
17:50
Hot Stocks
Hologic says FDA grants clearance for Aptima Mycoplasma genitalium assay »

Hologic announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.